NIH-funded research NIH-funded research

Exploring how to improve immunity to poliovirus through vaccines and gut health.

Official title: Understanding the Development of Mucosal Immunity to Poliovirus: Adjuvants and Modulation of the Enteric Microbiota

Funded at University of Vermont & St Agric College · NIH-10983632 · Data updated 2026-11-12

This study is looking at ways to boost the body's defenses against poliovirus, especially after getting the oral vaccine, by examining past trial data and samples, and seeing how gut bacteria and a new helper can improve immune responses, all to help make vaccines more effective for everyone.

More Microbiota research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startJuly 26, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$161,616
NIH project number1K23AI175660-01A1
Project IDNIH-10983632 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults over 21 years old who are at risk of poliovirus infection or transmission.

Less likely to help

Patients who are not at risk of poliovirus or those who have already been vaccinated with effective vaccines may not benefit from this research.

What this research studies

This research investigates how to enhance mucosal immunity to poliovirus, which is crucial for preventing its transmission and eradication. The study will analyze existing data and biological samples from previous clinical trials to understand immune responses during oral poliovirus vaccination. It will also explore the effects of gut microbiota and a new mucosal adjuvant on immune responses. By identifying effective immune profiles, the research aims to improve vaccine strategies against poliovirus.

Why it matters

Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against poliovirus and reduce its transmission.

How similar studies have gone: Previous research has shown promise in enhancing mucosal immunity through vaccine strategies, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Crothers, Jessica W. — University of Vermont & St Agric College
  • Study coordinator: Crothers, Jessica W.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.